Epileptic high-frequency oscillations occur in neonates with a high risk for seizures

Nicola Kuhnke1, Courtney J Wusthoff2, Eroshini Swarnalingam3

  • 1Department of Pediatric Neurology and Muscular Disease, University Medical Center, Freiburg, Germany.

Frontiers in Neurology
|January 23, 2023
PubMed

Insights

Neonatal brains can generate high-frequency oscillations (HFOs), which may serve as an early seizure biomarker. These epileptic brain activity markers were more frequent in neonates with abnormal EEG background activity.

Area of Science:

  • Neuroscience
  • Neonatal EEG research

Background:

  • Scalp high-frequency oscillations (HFOs) are recognized EEG markers of epileptic brain activity.
  • The necessary brain maturity for HFO generation remains unclear.
  • HFOs have been detected in children and neonates, with some studies linking their reduction to successful epilepsy treatment.

Purpose of the Study:

  • To investigate the capability of neonatal brains to generate HFOs.
  • To explore HFOs as a potential biomarker for seizures in high-risk neonates.

Main Methods:

  • Continuous EEGs from 38 neonates at risk for seizures were analyzed.
  • Visual analysis focused on scalp HFOs during 30 minutes of quiet sleep EEG.
  • EEGs from 14 patients were of sufficient quality for HFO analysis.

Main Results:

  • The average HFO rate was 0.34 ± 0.46/min.
  • Approximately 3.2% of HFOs were associated with epileptic spikes.
  • HFOs were significantly more frequent in EEGs with abnormal background activity (p = 0.005).

Conclusions:

  • Neonatal brains are capable of generating HFOs.
  • HFOs show potential as a biomarker for neonates at risk of seizures.
  • Preliminary data suggest HFOs are more common in neonates with altered background activity, warranting further investigation into their link with seizure generation and epilepsy development.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
240
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
520
Brain Waves01:23

Brain Waves

Brain waves are electrical signals generated by the neurons in the brain, which are regularly monitored to measure mental activities. Brain waves and their frequency ranges can be measured using an electroencephalogram or EEG. There are four main types of brain waves, each with distinct characteristics:
1.8K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
507